# US 7,812,144 B2 · Method for detecting human papillomavirus mRNA

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 7,812,144 B2
- Document ID: US7812144B2
- Status: Granted
- Kind: B2
- Application number: 12/483,900
- Filed: 2009-06-12
- Published: 2009-10-08
- Granted: 2010-10-12
- Earliest claimed: 2002-01-07
- Assignees: Norchip A/S
- Inventors: Frank Karlsen
- Web page: https://patentgrep.com/patent/US7812144B2

## CPC

- C12Q 1/708: {for papilloma}
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12Q 2600/16: Primer sets for multiplex assays
- Y10S 435/975: Kit
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

An in vitro method is provided for screening human female subjects to assess their risk of developing cervical carcinoma which comprises screening the subject for expression of mRNA transcripts from the E6 and optionally the L1 gene of human papillomavirus, wherein subjects positive for expression of L1 and/or E6 mRNA are scored as being at risk of developing cervical carcinoma. Kits for carrying out such methods are also provided.

## Claims

### Claim 1

A kit for use in the detection of mRNA transcripts from the E6 gene(s) of HPV, the kit containing primer-pairs which enable amplification of a region of E6 mRNA transcripts of HPV types 16, 18, 31, and 33, characterised in that the kit contains separate primer-pairs specific for E6 mRNA of each of the HPV types 16, 18, 31 and 33, the kit comprising one or more of, two or more of, or all of the following primer pairs and accompanying identification probes:
(SEQ ID NO: 175)
5′ gatgcaaggtcgcatatgagCCACAGGAGCGACCCAGAAA
and
(SEQ ID NO: 177)
5′ AATTCTAATACGACTCACTATAGGGAGAAGGATTCCCATCTCTATAT
ACTA
with probe
(SEQ ID NO: 19)
TATGACTTTGCTTTTCGGGA
or probe
(SEQ ID NO: 187)
ccagctTATGACTTTGCTTTTCGGGAagctgg;
(SEQ ID NO: 196)
5′ gatgcaaggtcgcatatgagGAAAACGATGAAATAGATGGAG
and
(SEQ ID NO: 203)
5′ AATTCTAATACGACTCACTATAGGGAGAAGGGGTCGTCTGCTGAGCT
TTCT
with probe
(SEQ ID NO: 32)
GAACCACAACGTCACACAATG
or probe
(SEQ ID NO: 198)
cgcatgGAACCACAACGTCACACAATGcatgcg;
(SEQ ID NO: 210)
5′ gatgcaaggtcgcatatgagACTGACCTCCACTGTTATGA
and
(SEQ ID NO: 211)
5′ AATTCTAATACGACTCACTATAGGGAGAAGGTATCTACTTGTGTGCT
CTGT
with probe
(SEQ ID NO: 50)
GGACAAGCAGAACCGGACACATCCAA
or probe
(SEQ ID NO: 215)
ccgtcgGGACAAGCAGAACCGGACACATCCAAcgacgg;
and
(SEQ ID NO: 221)
5′ GATGCAAGGTCGCATATGAGTATCCTGAACCAACTGACCTAT
and
(SEQ ID NO: 222)
5′ AATTCTAATACGACTCACTATAGGGAGAAGGTTGACACATAAACGA
ACTG
with probe
(SEQ ID NO: 59)
GGACAAGCACAACCAGCCACAGC
or probe
(SEQ ID NO: 225)
ccaagcGGACAAGCACAACCAGCCACAGCgcttgg.

### Claim 2 (depends on 1)

The kit of claim 1 which additionally contains a separate primer-pair which enables amplification of a region of E6 mRNA transcripts of HPV type 45, said primer-pair being specific for HPV type 45, wherein the kit comprises one or more of, two or more of, or all of the following primer pairs and accompanying identification probes:
5′ gatgcaaggtcgcatatgagCCACAGGAGCGACCCAGAAA
(SEQ ID NO: 175)
and
5′ AATTCTAATACGACTCACTATAGGGAGAAGGATTCCCATCTCTATATACTA
(SEQ ID NO: 177)
with probe
TATGACTTTGCTTTTCGGGA
(SEQ ID NO: 19)
or probe
ccagctTATGACTTTGCTTTTCGGGAagctgg;
(SEQ ID NO: 187)
5′ gatgcaaggtcgcatatgagGAAAACGATGAAATAGATGGAG
(SEQ ID NO: 196)
and
5′ AATTCTAATACGACTCACTATAGGGAGAAGGGGTCGTCTGCTGAGCTTTCT
(SEQ ID NO: 203)
with probe
GAACCACAACGTCACACAATG
(SEQ ID NO: 32)
or probe
cgcatgGAACCACAACGTCACACAATGcatgcg;
(SEQ ID NO: 198)
5′ gatgcaaggtcgcatatgagACTGACCTCCACTGTTATGA
(SEQ ID NO: 210)
and
5′ AATTCTAATACGACTCACTATAGGGAGAAGGTATCTACTTGTGTGCTCTGT
(SEQ ID NO: 211)
with probe
GGACAAGCAGAACCGGACACATCCAA
(SEQ ID NO: 50)
or probe
ccgtcgGGACAAGCAGAACCGGACACATCCAAcgacgg;
(SEQ ID NO: 215)
5′ GATGCAAGGTCGCATATGAGTATCCTGAACCAACTGACCTAT
(SEQ ID NO: 221)
and
5′ AATTCTAATACGACTCACTATAGGGAGAAGGTTGACACATAAACGAACTG
(SEQ ID NO: 222)
with probe
GGACAAGCACAACCAGCCACAGC
(SEQ ID NO: 59)
or probe
ccaagcGGACAAGCACAACCAGCCACAGCgcttgg;
(SEQ ID NO: 225)
and
5′ GATGCAAGGTCGCATATGAGAACCATTGAACCCAGCAGAAA
(SEQ ID NO: 261)
and
5′ AATTCTAATACGACTCACTATAGGGAGAAGGTCTTTCTTGCCGTGCCTGGTCA
(SEQ ID NO: 262)
with probe
GTACCGAGGGCAGTGTAATA
(SEQ ID NO: 108)
or probe
cgatcgGTACCGAGGGCAGTGTAATAcgatcg.
(SEQ ID NO: 342)

### Claim 3 (depends on 1)

The kit of claim 1 which additionally comprises the following primer-pair and identification probe specific for HPV type 52:
5′ GATGCAAGGTCGCATATGAGTTGTGTGAGGTGCTGGAAGAAT
(SEQ ID NO: 239)
and
5′ AATTCTAATACGACTCACTATAGGGAGAAGGCCCTCTCTTCTAATGTTT
(SEQ ID NO: 240)
with probe
GTGCCTACGCTTTTTATCTA.
(SEQ ID NO: 75)

### Claim 4 (depends on 1)

The kit of claim 1 which additionally comprises the following primer-pair and identification probe specific for HPV type 58:
5′ GATGCAAGGTCGCATATGAGTCTGTGCATGAAATCGAA
(SEQ ID NO: 245)
and
5′ AATTCTAATACGACTCACTATAGGGAGAAGGAGCACACTTTACATACTG
(SEQ ID NO: 246)
with probe
TTGCAGCGATCTGAGGTATATG.
(SEQ ID NO: 84)
